The horn of foreign capital public offering sounded! Summary of material information of listed companies this evening (110）！
First, important market news.
1. The first domestic Alzheimer's disease biological drug was approved.
According to the latest announcement on the official website of the State Food and Drug Administration, the marketing application for lecanemab injection, a new class of Alzheimer's disease drug submitted by Eisai, was approved, and the indication is ** early Alzheimer's disease. China is the third country after the United States and Japan to approve the marketing of lecanemab, indicating that the approval of new drugs is speeding up again.
2. The cost of buying a house has been reduced again! The interest rate of the first home loan of many banks in Nanjing has dropped to 39%
Since January 9, the interest rate on the first home loan in Nanjing has increased from 40% down to 39%, and the interest rate on second home loans remains unchanged at 45%。
China's auto market ended with retail sales of new energy vehicles increasing by 36% for the whole year2%
On January 9, data released by the China Passenger Car Association showed that China's retail sales of narrow passenger cars in 2023 increased by 5% year-on-year6%, with a total of 2,169 retail sales since the beginning of this year90,000 units, retail sales of narrow passenger cars in December 23 increased by 8 year-on-year5%, an increase of 131% to 23530,000 units.
The performance of new energy vehicles is particularly bright, with retail sales of new energy vehicles increasing by 36% year-on-year in 20232% to 77360,000 units, of which the retail sales of new energy vehicles in December increased by 47% year-on-year3%, to 9450,000 units.
4. The public offering of foreign capital sounded the clarion call for index investment! Morgan's latest response is here.
On January 9, J.P. Morgan Asset Management (China) exclusively responded to a reporter from China ** Daily that the company will continue to increase the layout of passive investment, combine global wisdom and local experience, and continuously enrich the ETF product lineage.
Combined with the advanced experience of overseas markets, the relevant research team believes that the scale of ETF products in China accounts for a significantly low proportion, and there is still a lot of room for development in terms of market scale and product richness.
The first share to be delisted in the year was determined: *ST Huayi's financial fraud for many years was terminated on the 16th.
6. Corporate Governance Department of the State Administration of Financial Regulation: Promote the normalization of disclosure of shareholders with major violations of laws and regulations.
7, Dong Yuhui's new account is on the air! Like to break 2200 million, with more than 4.5 million fans.
8. The Anhui Securities Regulatory Bureau took the measure of issuing a warning letter to Guohou Asset Management Co., Ltd.
9. iFLYTEK: It is planned to spin off its subsidiary, iFLYTEK Medical Technology Co., Ltd., to be listed on the Hong Kong Stock Exchange.
Second, the impact of listed companies on the good news.
1. Baili Technology: signed 83.8 billion yuan major contract.
2. Xinruida: Net profit in 2023 is expected to increase by 50%-75% year-on-year
3. Kangtai Biological: It is expected that the net profit in 2023 will be 8500 million yuan-9500 million yuan.
4. Chinatungsten High-tech: It is planned to purchase 100% of the equity of Persimmon Zhuyuan Company and resume trading on January 10.
5. Qin'an shares: net profit in 2023 is expected to increase by 37 year-on-year95%-54.5%
6. Huatai ** cancelled the repurchase of 4527 A shares850,000 shares.
7. Jingwei Hengrun: It is planned to repurchase the company's shares with 100 million yuan to 200 million yuan.
8. Beixin Road and Bridge: a total of 288.8 billion yuan highway construction contract.
9. iFLYTEK: It is planned to spin off its subsidiary, iFLYTEK Medical, to be listed on the Hong Kong Stock Exchange.
10. Sichuan Road and Bridge: The total amount of cumulative bid-winning projects in 2023 increased by 20% year-on-year07%
11. Shuanghuan Technology: 6859% of the shares signed an equity purchase agreement.
12. Haozhi Electromechanical: The company's harmonic reducer and other products can be applied to humanoid robots.
13. Lotus Health: It is expected that the net profit attributable to the parent company will increase by 160%-225% year-on-year in 2023
Third, the negative news affecting listed companies.
1. Jianyi Group: Shareholder Sun Yun intends to **143% of the company's shares.
Lianban Changbai Mountain: Shareholder Jilin Sengong 495% of the shares were released from the pledge.
Fourth, material information.
1. Lianchuang shares: According to the (2022) Lu 03 Xingchu No. 1 Criminal Verdict issued by the Intermediate People's Court of Zibo City, Shandong Province and the (2022) Lu Xingzhong No. 354 Criminal Verdict issued by the Higher People's Court of Shandong Province, the company received an enforcement payment of 3490 from the Intermediate People's Court of Zibo City, Shandong Province950,000 yuan.
2. Guangshengtang: Fujian Guangshengtang Pharmaceutical Co., Ltd. intends to jointly invest in the establishment of Guangfulai (Beijing) International Biotechnology Co., Ltd. with its related party Fuzhou Aotai Phase IX Investment Partnership (Limited Partnership). The registered capital of Guangfulai is 50 million yuan, of which the company intends to contribute 35 million yuan in monetary terms, accounting for 70% of the registered capital of Guangfulai; Aotai Phase 9 plans to contribute 15 million yuan in monetary terms, accounting for 30% of the registered capital of Guangfulai.
3. Sinocare Biologics: Illumina and Sinocare Biosensing Co., Ltd. announced that they have officially reached a strategic cooperation, and the two parties will start with the localization of ISCAN's high-end chip scanners, and use the technical advantages and channel resources of both parties to jointly expand the application of genomics in precision health management.
4. Tianyuan Environmental Protection: As the leader of the consortium, the company and the North China Municipal Engineering Design and Research Institute, a member of the consortium, have become the winning bidders of the "EPC" project of "General Contracting (EPC) of the New Engineering Design, Procurement and Construction of the Second Sewage Treatment Plant in Zhanyi District".
5. Laier Technology (SH 688683): The company and its subsidiaries use no more than 300 million yuan (including 300 million yuan) of their own idle funds to purchase wealth management products from banks, ** companies and other financial institutions.
6. Tongdahai: The company intends to set up a wholly-owned subsidiary in the Hong Kong Special Administrative Region of the People's Republic of China with its own funds, "Tongdahai (Hong Kong) Technology *** tentative name", with a total planned investment of 100,000 US dollars. After the completion of the capital contribution, Tongdahai Hong Kong Company will become a wholly-owned subsidiary of the company.
7. Longjian Co., Ltd.: The second project of Longjian Road and Bridge in Heilongjiang Province, a subsidiary of the company, was identified as the bidder for the construction project of the reconstruction and expansion project of the Suiba boundary to Bayan section of the provincial highway Suihua to Shangzhi Highway. The winning bid was 778,411,744$22.
8. ST Shimao: The company added 4$8.3 billion was not paid on time. The company and its subsidiaries have accumulated 26$5.2 billion in principal and interest failed to be paid on time.
9. Xinruida: It is expected that the net profit in 2023 will be 15.9 billion yuan—18.5 billion yuan, a year-on-year increase of 50%-75%.
10. Digital Politics (SZ 300075): Beijing Digital Politics Technology Co., Ltd. plans to invest in the establishment of a subsidiary in Xi'an City, Shaanxi Province, and the registered name of the subsidiary is Xi'an Digital Politics Technology, with a registered capital of 10 million yuan, and the company's own funds are used to subscribe and contribute, with a shareholding ratio of 100%.